Last reviewed · How we verify
3 ampoules of Hylan GF-20 — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
3 ampoules of Hylan GF-20 (3 ampoules of Hylan GF-20) — University of Sao Paulo General Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 3 ampoules of Hylan GF-20 TARGET | 3 ampoules of Hylan GF-20 | University of Sao Paulo General Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 3 ampoules of Hylan GF-20 CI watch — RSS
- 3 ampoules of Hylan GF-20 CI watch — Atom
- 3 ampoules of Hylan GF-20 CI watch — JSON
- 3 ampoules of Hylan GF-20 alone — RSS
Cite this brief
Drug Landscape (2026). 3 ampoules of Hylan GF-20 — Competitive Intelligence Brief. https://druglandscape.com/ci/3-ampoules-of-hylan-gf-20. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab